p16 Overexpression Identifies HPV-positive Vulvar Squamous Cell Carcinomas

Two types of vulvar squamous cell carcinomas (VSCCs) are recognized according to their relationship to human papillomavirus (HPV). Basaloid or warty carcinomas are considered HPV-associated tumors, whereas differentiated keratinizing neoplasms are considered non-HPV–associated. Recently, immunohistochemical detection of p16 and p53 has been proposed to differentiate these 2 types of VSCCs. We conducted a histologic study with immunohistochemical evaluation of p16 and p53 and HPV detection and typing by polymerse chain reaction using 2 different sets of primers in 92 cases of VSCCs to evaluate the usefulness of immunohistochemistry in the classification of VSCCs and to describe the clinico-pathologic characteristics of both types of VSCCs. HPV was detected in 16/92 (17.4%) specimens, HPV16 being identified in 75% of positive cases. A significant number of discrepancies between histology and HPV detection were observed, with 37.5% of HPV-positive tumors being keratinizing and 9.2% of HPV-negative carcinomas showing basaloid or warty features. Diffuse positivity for p16 and p53 was observed in 100% and 6.2% of HPV-positive tumors and in 2.3% and 64.5% of HPV-negative neoplasms, respectively. The sensitivity and specificity of p16 immunostaining to detect HPV-associated carcinomas (100% and 98.7%, respectively) were better than those of histologic criteria (93.8% and 35.5%) and of p53 negative stain (62.5% and 93.4%). Vulvar intraepithelial neoplasia grade 3 of basaloid/warty type was identified in 53.8% HPV-positive tumors, including 3 keratinizing tumors. All these cases were p16 positive and p53 negative. Vulvar intraepithelial neoplasia grade 3 of differentiated type was observed in 45.6% of HPV-negative cases; 90.8% of them were positive for p53 but all were negative for p16. No differences in age, stage, or development of recurrence were observed between HPV-positive and negative tumors. In summary, the current morphologic criteria to discriminate HPV-positive and negative VSCCs have a significant overlap. Immunostaining for p16 is a reliable marker for HPV-positive VSSCs, which improves the results of histologic classification.

[1]  Danielle W. Lu,et al.  Prevalence of High-Risk Human Papillomavirus DNA in Nonkeratinizing (Cylindrical Cell) Carcinoma of the Sinonasal Tract: A Distinct Clinicopathologic and Molecular Disease Entity , 2005, The American journal of surgical pathology.

[2]  S. Riethdorf,et al.  p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. , 2004, Human pathology.

[3]  T. Bjørge,et al.  p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas. , 2004, Gynecologic oncology.

[4]  S. Cajal,et al.  Immunohistochemical Staining for p16 and p53 in Premalignant and Malignant Epithelial Lesions of the Vulva , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  Hanlin L. Wang,et al.  Detection of Human Papillomavirus DNA and Expression of p16, Rb, and p53 Proteins in Small Cell Carcinomas of the Uterine Cervix , 2004, The American journal of surgical pathology.

[6]  J. Pintos,et al.  Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. , 2004, Gynecologic oncology.

[7]  Hanlin L. Wang,et al.  Expression of p16, Rb, and p53 Proteins in Squamous Cell Carcinomas of the Anorectal Region Harboring Human Papillomavirus DNA , 2003, Modern Pathology.

[8]  N. Kiviat,et al.  p16INK4a Expression Correlates with Degree of Cervical Neoplasia: A Comparison with Ki-67 Expression and Detection of High-Risk HPV Types , 2003, Modern Pathology.

[9]  P. Carli,et al.  Vulvar carcinoma associated with lichen sclerosus. Experience at the Florence, Italy, Vulvar Clinic. , 2003, The Journal of reproductive medicine.

[10]  S. Bonin,et al.  Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico‐pathologic entity , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[11]  H. Dienes,et al.  Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. , 2003, The American journal of pathology.

[12]  A. Haitel,et al.  p16INK4a Is a Useful Marker for the Diagnosis of Adenocarcinoma of the Cervix Uteri and Its Precursors: An Immunohistochemical Study With Immunocytochemical Correlations , 2003, The American journal of surgical pathology.

[13]  M. von Knebel Doeberitz,et al.  p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia , 2002, The American journal of surgical pathology.

[14]  S. Naudé,et al.  Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. , 2002, Gynecologic oncology.

[15]  P. Snijders,et al.  GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.

[16]  M. Stoler,et al.  p16 Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia , 2002 .

[17]  Dianne Miller,et al.  Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. , 2002, Gynecologic oncology.

[18]  M. Rubin,et al.  Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. , 2001, The American journal of pathology.

[19]  W. R. Hart.  Vulvar intraepithelial neoplasia: historical aspects and current status. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[20]  Bin Yang,et al.  Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. , 2000, The American journal of surgical pathology.

[21]  M. Roussel.  The INK4 family of cell cycle inhibitors in cancer , 1999, Oncogene.

[22]  Wim Quint,et al.  Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus , 1999, Journal of Clinical Microbiology.

[23]  E. Lerma,et al.  Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[24]  W. Quint,et al.  Technical Advance Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses , 1998 .

[25]  P W Hamilton,et al.  Inter‐ and intra‐observer variation in the histopathological reporting of cervical squamous in traepithelial lesion susing a modified Bethesda grading system , 1998, British journal of obstetrics and gynaecology.

[26]  G. Fleuren,et al.  Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. , 1998, Gynecologic oncology.

[27]  G. Fleuren,et al.  Human Papillomavirus Infection in Squamous Cell Carcinoma of the Vulva, in Various Synchronous Epithelial Changes and in Normal Vulvar Skin☆ , 1997 .

[28]  C. Crum,et al.  Pathobiology of vulvar squamous neoplasia. , 1997, Current Opinion in Obstetrics and Gynecology.

[29]  G. Fleuren,et al.  The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva. , 1997, International Journal of Gynecological Cancer.

[30]  B. Monk,et al.  Prognostic significance of human papillomavirus DNA in vulvar carcinoma , 1995 .

[31]  A. Chumakov,et al.  Carcinoma of the vulva: HPV and p53 mutations. , 1994, Oncogene.

[32]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[33]  M. Schiffman,et al.  Basaloid and Warty Carcinomas of the Vulva: Distinctive Types of Squamous Cell Carcinoma Frequently Associated with Human Papillomaviruses , 1993, The American journal of surgical pathology.

[34]  C. Crum,et al.  Vulvar squamous cell carcinoma and papillomaviruses: two separate entities? , 1991, American journal of obstetrics and gynecology.

[35]  K. Shah,et al.  Probable Nonpapillomavirus Etiology of Squamous Cell Carcinoma of the Vulva in Older Women: A Clinicopathologic Study Using In Situ Hybridization and Polymerase Chain Reaction , 1991, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[36]  G. Snow,et al.  The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. , 1990, The Journal of general virology.

[37]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.